Boehringer Ingelheim Pharmaceuticals Inc. et al v. Boehringer Ingelheim Corporation et al
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation |
| Ajanta Pharma Limited |
| 1:2023cv00848 |
| August 4, 2023 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 12, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2; 10,258,637 B2; 11,090,323 B2. (Attachments: #1 Consent Judgment)(nmf) |
| Filing 9 CONSENT JUDGMENT (CASE CLOSED) Signed by Judge Colm F. Connolly on 9/12/2023. Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC(nmf) |
| Filing 8 PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Filing 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC(nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC (rjb) |
| Filing 6 Summons Issued as to Ajanta Pharma Limited on 8/4/2023. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2 ;10,258,637 B2 ;11,090,323 B2. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/17/2022. Date of Expiration of Patent: See Attached. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ajanta Pharma Limited ( Filing fee $ 402, receipt number ADEDC-4195376.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
